BNP Paribas Maintains Medical Properties Trust Inc(MPW.US) With Buy Rating, Raises Target Price to $9
Exane BNP Paribas Upgrades Medical Properties Trust to Outperform, Raises Price Target to $9
Medical Properties Trust Is Maintained at Sector Perform by RBC Capital
Medical Properties Trust Analyst Ratings
Wells Fargo Maintains Underweight on Medical Properties Trust, Raises Price Target to $5
RBC Raises Price Target on Medical Properties Trust to $5 From $4, Keeps Sector Perform, Speculative Risk
Wells Fargo Downgrades Medical Properties Trust Inc(MPW.US) to Sell Rating, Cuts Target Price to $5
Wells Fargo Initiates Medical Properties Trust Inc(MPW.US) With Sell Rating, Announces Target Price $5
Truist Financial Maintains Medical Properties Trust Inc(MPW.US) With Hold Rating
Colliers Securities Maintains Medical Properties Trust Inc(MPW.US) With Buy Rating, Maintains Target Price $6.5
Medical Properties Trust: Buy Rating Affirmed Amid Improved Financial Stability and Strategic Asset Management
Truist Financial Initiates Medical Properties Trust Inc(MPW.US) With Hold Rating
Wells Fargo Initiates Medical Properties Trust Inc(MPW.US) With Sell Rating, Announces Target Price $4
Sell Rating for Medical Properties Trust Amidst Bankruptcy Concerns and Debt Challenges
Truist Financial Maintains Medical Properties Trust Inc(MPW.US) With Hold Rating, Cuts Target Price to $4
Medical Properties Trust Analyst Ratings
Raymond James Maintains Medical Properties Trust Inc(MPW.US) With Sell Rating
Mizuho Securities Maintains Medical Properties Trust Inc(MPW.US) With Hold Rating, Cuts Target Price to $5
Medical Properties Trust Analyst Ratings
Mizuho Maintains Neutral on Medical Properties Trust, Lowers Price Target to $5